GAG
GILD icon

GM Advisory Group’s Gilead Sciences GILD Stock Holding History

GM Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,585
Closed -$263K – 245
2024
Q1 		$263K Buy
+3,585
New +$276K 0.02% 194
2018
Q4 		– Sell
-2,856
Closed -$221K – 112
2018
Q3 		$221K Buy
2,856
+1
+0% +$76 0.07% 104
2018
Q2 		$202K Sell
2,855
-164
-5% -$11.6K 0.06% 116
2018
Q1 		$228K Sell
3,019
-68
-2% -$5.41K 0.07% 110
2017
Q4 		$221K Sell
3,087
-34
-1% -$2.58K 0.06% 116
2017
Q3 		$253K Sell
3,121
-444
-12% -$34K 0.08% 96
2017
Q2 		$252K Sell
3,565
-341
-9% -$22.7K 0.08% 93
2017
Q1 		$265K Buy
+3,906
New +$275K 0.09% 81

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GM Advisory Group's GILD Position: Q2 2024 in Review

GM Advisory Group sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 3,585 shares — an estimated $263K sold.

GM Advisory Group first reported a position in GILD in Q1 2017 and held it in 8 quarters. The position peaked at $265K in Q1 2017. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • GM Advisory Group reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
  • GM Advisory Group sold 3,585 Gilead Sciences shares in Q2 2024, an estimated $263K.
  • GM Advisory Group first reported a position in Gilead Sciences in Q1 2017 and held it in 8 quarters.
  • GM Advisory Group's Gilead Sciences position peaked at $265K in Q1 2017.
  • 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on GM Advisory Group's 13F filing for Q2 2024, filed 12 Aug 2024.